1) Triple negative
三阴性
1.
Triple negative breast cancer:clinicopathological characteristics and the significance of CK19 expression;
三阴性乳腺癌的临床病理特征及与CK19表达的相关性研究
2.
Clinical analysis of 69 cases of triple negative breast cancer;
69例三阴性乳腺癌临床分析
2) Triple-negative
三阴性
1.
Triple-negative breast cancers were immunohistochemically defined by a lack of expression of estrogen receptor (ER),progesterone receptor (PR) and Human epidermal growth receptor-2 (Her-2).
目的:了解三阴性乳腺癌临床病理特征及其预后。
2.
Objective: To compare the clinical features,natural history,and outcomes for women with triple-negative breast cancer with women with other types of breast cancer.
【目的】分析受体三阴性乳腺癌与其它亚型乳腺癌临床特征及影响受体三阴性乳腺癌预后的因素,为乳腺癌的个体化治疗提供依据。
3.
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors(ER/PR) and HER2 protein.
根据免疫组化染色的特征,将ER、PR和HER2受体均阴性的乳腺癌称之为受体三阴性乳腺癌,三阴性乳腺癌是具有独特生物学及临床特征的乳腺癌亚型,与基底细胞样乳腺癌有较高的一致性,复发早、进展快、生存短。
3) triple negative
受体三阴性
1.
Advances of molecular characteristics and treatment in triple negative breast cancers;
受体三阴性乳腺癌的分子特征与治疗研究进展
4) triple-negative breast cancer
三阴性乳腺癌
1.
Objective:To analyze the clinicopathological features, parameters of molecular biology, survival rate, and prognostic factors in triple-negative breast cancer patients.
目的:探讨三阴性乳腺癌患者的临床病理特点、分子生物学特性、生存率以及影响预后的因素。
5) trialkali photocathode
三碱性光电阴极
6) Triple negative
三阴
1.
Objective: To analyze clinical and pathological features and to observe prognostic factors in triple negative breast cancer (TNBC) .
目的:探讨三阴型乳腺癌(triple negative breast cancer,TNBC)的临床病理特征以及预后影响因素,进一步分析表皮生长因子受体(epidermal growth factorreceptor,EGFR)、上皮性钙粘附蛋白(epithelial cadherin,E-cadherin)、雄激素受体(androgen receptor,AR)在TNBC和非三阴型乳腺癌(non-TNBC)表达及临床意义。
补充资料：革兰氏阴性菌
用革兰氏染色法染色后呈红色或土黄色的细菌。细胞壁有脂多糖成分，不能被龙胆紫(或结晶紫)染色，用稀复红(或沙黄)复染时显色。如大肠杆菌、痢疾杆菌和伤寒杆菌等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条